Catalyst Funds Management Pty LTD Conmed Corp Transaction History
Catalyst Funds Management Pty LTD
- $455 Billion
- Q3 2024
A detailed history of Catalyst Funds Management Pty LTD transactions in Conmed Corp stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 300 shares of CNMD stock, worth $21,395. This represents 0.0% of its overall portfolio holdings.
Number of Shares
300Holding current value
$21,395% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CNMD
# of Institutions
308Shares Held
33.7MCall Options Held
123KPut Options Held
24.2K-
Black Rock Inc. New York, NY4.99MShares$356 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.53MShares$252 Million0.0% of portfolio
-
Earnest Partners LLC Atlanta, GA2.78MShares$199 Million0.91% of portfolio
-
Capital Research Global Investors Los Angeles, CA1.54MShares$110 Million0.02% of portfolio
-
Bank Of America Corp Charlotte, NC1.37MShares$97.7 Million0.01% of portfolio
About CONMED Corp
- Ticker CNMD
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 30,482,400
- Market Cap $2.17B
- Description
- CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide uni...